Early Proactive Therapeutic Drug Monitoring of Infliximab in Children: EPIC Study

NCT05280405 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Bowel Diseases

Interventions

DRUG: Infliximab

Sponsor

IRCCS Burlo Garofolo